Keywords: سرطان ریه غیر سلولی کوچک; Aptamer; Non-small-cell lung cancer; Human serum; Clinical pleural effusion;
مقالات ISI سرطان ریه غیر سلولی کوچک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان ریه غیر سلولی کوچک; metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: سرطان ریه غیر سلولی کوچک; PD-1; programed cell death-1; PD-L1; programmed cell death ligand 1; NSCLC; non-small-cell lung cancer; OS; overall survival; PFS; progression-free survival; ORR; objective response rate; irAEs; immune-related adverse events; RECIST; response evaluation c
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Personalised prescriptions; Radiotherapy; Personalised medicine; Dose fractionation;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Immunotherapy; Combination therapy; Cancer biology; Systems biology;
Keywords: سرطان ریه غیر سلولی کوچک; Antibody drug conjugate; Non-small-cell lung cancer; Small-cell lung cancer; Mesothelioma; Thoracic malignancies;
Keywords: سرطان ریه غیر سلولی کوچک; NSCLC; non-small-cell lung cancer; PDX; patient-derived xenograft model; ALK; anaplastic lymphoma kinase; YHIM; Yonsei Human In Mouse; MAF; mutant allele frequency; H&E; hematoxylin and eosin; Non-small-cell lung cancer; Patient-derived xenograft; Preclin
Keywords: سرطان ریه غیر سلولی کوچک; AF; S-triethyl phosphine gold(I)-2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside (Auranofin); AP-1; activator protein 1; ARE; antioxidant response element; ASK1; apoptosis signal-regulating kinase 1; [Au(dppe)2]Cl; [bis(diphenylphosphino)ethane]gold(I)
Keywords: سرطان ریه غیر سلولی کوچک; ICIs; immune checkpoint inhibitors; irAEs; immune-related adverse events; NK-1R; neurokinin-1 receptor; NSCLC; non-small-cell lung cancer; SJS; Stevens-Johnson syndrome; immune checkpoint inhibitors; immune-related adverse events; nivolumab; Stevens-Johns
Keywords: سرطان ریه غیر سلولی کوچک; Nivolumab; Non-small-cell lung cancer; Immune-related adverse event; Hu paraneoplastic antibody; Neurological toxicity; Dysphasia;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small cell lung cancer; Geriatric Nutritional Risk Index; Predictive and prognostic factor; AUC; area under the curve; BVI; blood vessel invasion; CEA; carcinoembryonic antigen; CS; cancer-specific survival; CT; computed tomography; CYFRA; cytokeratin
Keywords: سرطان ریه غیر سلولی کوچک; Next-generation sequencing; Non-small-cell lung cancer; Diagnosis; Therapy; Drug resistance;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Cytokine; Radiotherapy; Lung toxicity; Biomarker;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Pirfenidone; TGF-β; Epithelial-mesenchymal transition; Chemoresistance;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Subtyping; Well differentiated; Poorly differentiated; Radiomics;
Keywords: سرطان ریه غیر سلولی کوچک; Biomarkers; Checkpoint molecules; Cytokines; Glioblastoma; Immunotherapy; Microbiome; Mutational landscape; CB; Cintredekin besudotox; CNS; Central nervous system; CTLA-4; Cytotoxic T lymphocyte antigen 4; CyTOF; Cytometry by time-of-flight; EGFR; Epiderm
Keywords: سرطان ریه غیر سلولی کوچک; AKT; protein kinase B (a serine/threonine kinase); CAF; cancer-associated fibroblast; CTGF; connective tissue growth factor; ECM; extracellular matrix; EGFR; epidermal growth factor receptor; EMT; epithelial-mesenchymal transition; ER; estrogen receptor;
Keywords: سرطان ریه غیر سلولی کوچک; DCR; disease control rate; D-ILD; drug-induced interstitial lung disease; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; NSCLC; non-small-cell lung cancer; ORR; objective response rate; OS; overall survival; PD; progressive disease,
Keywords: سرطان ریه غیر سلولی کوچک; Lung cancer; Non-small-cell lung cancer; Radiofrequency ablation; Microwave ablation; Cryoablation;
Keywords: سرطان ریه غیر سلولی کوچک; Heart radiation; Lung radiation; Chemoradiation; Non-small-cell lung cancer;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Histology; Adenocarcinoma; Brazil and epidemiology
Keywords: سرطان ریه غیر سلولی کوچک; Circulating cell free DNA; Non-small-cell lung cancer; Diagnosis; Meta-analysis
Keywords: سرطان ریه غیر سلولی کوچک; Post-operative radiotherapy; Non-small-cell lung cancer; Review;
Keywords: سرطان ریه غیر سلولی کوچک; CHM; Chinese herbal medicine; NSCLC; non-small-cell lung cancer; BSC; best supporting care; PFS; progression-free survival; QOL; quality of life; FACT-L; Functional Assessment of Cancer Therapy-Lung; FAS; full analysis set; PPS; per-protocol analysis set;
Keywords: سرطان ریه غیر سلولی کوچک; Brain metastases; Non-small-cell lung cancer; Quality of life; Cost;
Keywords: سرطان ریه غیر سلولی کوچک; AUC; area under the curve; BVI; blood vessel invasion; CEA; carcino embryonic antigen; CT; computed tomography; CYFRA; cytokeratin 19 fragment; FDG-PET; fluorodeoxyglucose-positron emission tomography; LVI; lymphatic vessel invasion; MRI; magnetic resonan
Keywords: سرطان ریه غیر سلولی کوچک; SCLC; small cell lung cancer; NSCLC; non-small-cell lung cancer; LNCaP; human prostate adenocarcinoma; DU-145; human prostate carcinoma; MDA-MB-231; human breast adenocarcinoma; BGC-823; human gastric cancer; SI; selectivity index; SAR; structure-activi
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Elderly; Treatment; Survival;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; H1299 cells; A549 cells; Cepharanthine; Apoptosis; ROS;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Next generation sequencing; Genotype; EGFR; ALK; Driver oncogene; MET; ROS1; MET; Adenocarcinoma; Squamous cell carcinomas;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Adjuvant chemotherapy; Preferences; Decision-making;
Keywords: سرطان ریه غیر سلولی کوچک; Model; Military health system; Mortality; Non-small-cell lung cancer; Risk prediction;
Keywords: سرطان ریه غیر سلولی کوچک; Traditional herbal medicine; Non-small-cell lung cancer; Chemotherapy; Systematic review; Meta-analysis;
Keywords: سرطان ریه غیر سلولی کوچک; Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Keywords: سرطان ریه غیر سلولی کوچک; drug resistance; gefitinib; non-small-cell lung cancer; proteomics; secretomics
Keywords: سرطان ریه غیر سلولی کوچک; Small-cell lung cancer; Liver metastasis; Procalcitonin; Prognostic factor; Non-small-cell lung cancer
Keywords: سرطان ریه غیر سلولی کوچک; Lung cancer; Non-small-cell lung cancer; Never smokers; Epidermal growth factor receptor; EGFR; Anaplastic lymphoma kinase; ALK; KRAS; Tumor genotype; Failure; Bone specimen; Core biopsy; Molecular testing;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Chemotherapy; Target therapies; Ocular toxicity; Ophthalmology;
Keywords: سرطان ریه غیر سلولی کوچک; DCF-DA; 2,7-dichlorofluorescein diacetate; 8-iso-PGF2α; 8-iso-prostaglandin F2α; NSAIDs; Non-steroidal anti-inflammatory drugs; NSCLC; Non-small-cell lung cancer; PIA; Phospho-ibuprofen amide; ROS; Reactive oxygen species; Lung cancer; Liposome; Phospho
Keywords: سرطان ریه غیر سلولی کوچک; 2 DE; 2-dimensional electrophoresis; ABPP; activity-based protein profiling; BFGF; basic fibroblast growth factor; CML; chronic myeloid leukemia; CRC; colorectal cancer; DIGE; differential in gel electrophoresis; EGF(R); epidermal growth factor (receptor)
Keywords: سرطان ریه غیر سلولی کوچک; JCOG; Japan Clinical Oncology Group; SCLC; small cell lung cancer; ED; extensive disease; OS; overall survival; WJOG; West Japan Oncology Group; NSCLC; non-small-cell lung cancer; EGFR; epidermal growth factor receptor; PFS; progression-free survival; TKI
Keywords: سرطان ریه غیر سلولی کوچک; Bevacizumab; ISG15 expression; Non-small-cell lung cancer; Refractory; Second-line therapy; Topotecan;
Keywords: سرطان ریه غیر سلولی کوچک; Lung cancer; Non-small-cell lung cancer; Never smokers; Epidermal growth factor receptor; EGFR; Anaplastic lymphoma kinase; ALK; KRAS;
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; KRAS mutation; Circulating tumor cells; Circulating tumor DNA;
Use of erlotinib and thalidomide in advanced NSCLC patients with acquired resistance to erlotinib: A pilot study
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; Thalidomide; EGFR-TKI; Acquired resistance; Erlotinib;
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; PD-L1 expression; Circulating tumor cells; Monitoring of response; Immunotherapy; Anti-PD1;
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06)
Keywords: سرطان ریه غیر سلولی کوچک; ALK; anaplastic lymphoma kinase gene; CGA; comprehensive geriatric assessment; CT; computed-tomography scan; EGFR; epidermal growth-factor; ECOG PS; Eastern Cooperative Oncology Group performance status; La-NSCLC; locally advanced non-small-cell lung ca
A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404
Keywords: سرطان ریه غیر سلولی کوچک; Non-small-cell lung cancer; EGFR; Bevacizumab; Afatinib; EGFR-TKI; Phase Ib;
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism
Keywords: سرطان ریه غیر سلولی کوچک; BIM deletion polymorphism; Non-small-cell lung cancer; Epidermal growth factor receptor mutation; EGFR tyrosine kinase inhibitor; Chemotherapy;
First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective
Keywords: سرطان ریه غیر سلولی کوچک; Cost-Effectiveness; Immunotherapy; Non-small-cell lung cancer; Pembrolizumab;